These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pai MP Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238 [TBL] [Abstract][Full Text] [Related]
3. Drug disposition in obesity and protein-energy malnutrition. Boullata JI Proc Nutr Soc; 2010 Nov; 69(4):543-50. PubMed ID: 20696092 [TBL] [Abstract][Full Text] [Related]
5. Composition of the fat-free mass in obese and nonobese children: matched case-control analyses. Haroun D; Wells JC; Williams JE; Fuller NJ; Fewtrell MS; Lawson MS Int J Obes (Lond); 2005 Jan; 29(1):29-36. PubMed ID: 15520827 [TBL] [Abstract][Full Text] [Related]
6. Skinfold thickness, body fat percentage and body mass index in obese and non-obese Indian boys. Chatterjee S; Chatterjee P; Bandyopadhyay A Asia Pac J Clin Nutr; 2006; 15(2):231-5. PubMed ID: 16672208 [TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on the pharmacokinetics of drugs in humans. Hanley MJ; Abernethy DR; Greenblatt DJ Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334 [TBL] [Abstract][Full Text] [Related]
9. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing. Kendrick JG; Carr RR; Ensom MH Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823 [TBL] [Abstract][Full Text] [Related]
10. Anesthesia in the obese patient: pharmacokinetic considerations. Casati A; Putzu M J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132 [TBL] [Abstract][Full Text] [Related]
11. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling. Bouzom F; Walther B Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658 [TBL] [Abstract][Full Text] [Related]
14. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651 [TBL] [Abstract][Full Text] [Related]
15. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations. Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076 [TBL] [Abstract][Full Text] [Related]
16. Body composition and energy expenditure: relationship and changes in obese subjects before and after biliopancreatic diversion. Tacchino RM; Mancini A; Perrelli M; Bianchi A; Giampietro A; Milardi D; Vezzosi C; Sacco E; De Marinis L Metabolism; 2003 May; 52(5):552-8. PubMed ID: 12759883 [TBL] [Abstract][Full Text] [Related]
17. DXA measurements confirm that parental perceptions of elevated adiposity in young children are poor. Miller JC; Grant AM; Drummond BF; Williams SM; Taylor RW; Goulding A Obesity (Silver Spring); 2007 Jan; 15(1):165-71. PubMed ID: 17228044 [TBL] [Abstract][Full Text] [Related]
18. Assessment of body fatness in childhood obesity: evaluation of laboratory and anthropometric techniques. Bandini LG; Dietz WH J Am Diet Assoc; 1987 Oct; 87(10):1344-8. PubMed ID: 3655163 [TBL] [Abstract][Full Text] [Related]
19. Dosing in obesity: a simple solution to a big problem. Han PY; Duffull SB; Kirkpatrick CM; Green B Clin Pharmacol Ther; 2007 Nov; 82(5):505-8. PubMed ID: 17952107 [TBL] [Abstract][Full Text] [Related]
20. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Sewell MF; Huston-Presley L; Super DM; Catalano P Am J Obstet Gynecol; 2006 Oct; 195(4):1100-3. PubMed ID: 16875645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]